PLOD2 is also directly regulated by miR-26a-5p and miR-26b-5p, and PLOD2 expression is a potential prognostic marker for patients with bladder cancer (Miyamoto et al., 2016) and renal cell carcinoma (Kurozumi et al., 2016). This evidence concerns the gene PLOD2 and urinary bladder carcinoma.